Basilea Pharmaceutica AG
BPMUF
$67.75
$6.4110.45%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.98% | -72.85% | -1.51% | 186.65% | -3.31% |
| Total Depreciation and Amortization | 8.97% | -66.15% | -1.51% | 260.22% | -3.30% |
| Total Amortization of Deferred Charges | 8.99% | 5.88% | -1.53% | -4.35% | -3.31% |
| Total Other Non-Cash Items | 8.98% | 283.61% | 1.51% | 64.24% | 3.31% |
| Change in Net Operating Assets | -8.98% | -559.31% | -1.44% | -97.76% | -3.31% |
| Cash from Operations | 8.98% | -60.10% | -1.51% | 229.30% | -3.31% |
| Capital Expenditure | -9.02% | 74.78% | 1.50% | -178.27% | 3.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00% | -3.31% |
| Other Investing Activities | -9.09% | -213.33% | 1.79% | 42.66% | 3.30% |
| Cash from Investing | -8.94% | 68.20% | 1.51% | -609.56% | -3.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 0.00% |
| Issuance of Common Stock | 0.00% | 244.90% | 0.00% | -93.64% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -8,762.13% | 0.00% | -214.19% | 0.00% |
| Cash from Financing | -8.98% | -64,284.00% | 1.57% | 99.83% | 3.31% |
| Foreign Exchange rate Adjustments | -9.84% | 81.85% | 1.47% | -156.55% | -3.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.98% | -85.53% | -1.51% | 1,018.78% | -3.31% |